1-3 of 3
Nisar Ahmad, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Curing Multiple Myeloma (MM) with High-Risk Features Defined by Metaphase Cytogenetic Abnormalities (CA), High LDH (>300U/L) and Gene Expression Profiling (GEP)-70 Score >=+o.66

Bart Barlogie, MD, PhD, Alan Mitchell, Frits van Rhee, MD, PhD, Sarah Waheed, MD, Saad Z Usmani, MD FACP, Monica Grazziutti, MD, Alejandro Restrepo, MD, Al-Ola Abdallah, MD, Nisar Ahmad, MD, Senu Apewokin, MD, Shebli Atrash, MD, Aziz Bakhous, M.D., Sajjad Haider, MD, Surachit Kumar, MD, Jameel Muzaffar, MD, Zainab Shahid, MD, John Crowley, PhD
Journal: Blood
Blood (2012) 120 (21): 1850.
https://doi.org/10.1182/blood.V120.21.1850.1850
Published: 2012
Journal Articles

Patterns of CNS Involvement in Relapsed and/or Refractory Multiple Myeloma.

Al-Ola Abdallah, MD, Shebli Atrash, MD, Jameel Muzaffar, MD, Nisar Ahmad, MD, Sajjad Haider, MD, Monica Grazziutti, MD, Senu Apewokin, MD, Zainab Shahid, MD, Alejandro Restrepo, MD, Sarah Waheed, MD, Frits van Rhee, MD, PhD, Bart Barlogie, MD, PhD, Saad Z Usmani, MD FACP
Journal: Blood
Blood (2012) 120 (21): 2925.
https://doi.org/10.1182/blood.V120.21.2925.2925
Published: 2012
Journal Articles

Phase II Study of Pomalidomide (Pom) in Genomically Defined High Risk Relapsed and Refractory Multiple Myeloma (RRMM)

Saad Z Usmani, MD, FACP, Emily Hansen, MS, Doug Steward, Sarah Waheed, MD, Susan B. Panozzo, Nathan M Petty, Shebli Atrash, MD, Al-Ola Abdallah, MD, Nisar Ahmad, MD, Antje Hoering, John Crowley, PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4083.
https://doi.org/10.1182/blood.V120.21.4083.4083
Published: 2012